Wu-Mei-Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells

Wu-Mei-Wan (WMW) is a Chinese herbal formula used to treat type 2 diabetes. In this study, we aimed to explore the effects and mechanisms of WMW on insulin resistance in HepG2 cells. HepG2 cells were pretreated with palmitate (0.25 mM) to impair the insulin signaling pathway. Then, they were treated...

詳細記述

保存先:
書誌詳細
出版年:Evid Based Complement Alternat Med
主要な著者: Yang, Xueping, Li, Lingli, Fang, Ke, Dong, Ruolan, Li, Jingbin, Zhao, Yan, Dong, Hui, Yi, Ping, Huang, Zhaoyi, Chen, Guang, Lu, Fuer
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi 2017
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5591966/
https://ncbi.nlm.nih.gov/pubmed/28928791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7283241
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料